Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602 · see citing works

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · see citing works

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E. P., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,843 · see citing works

Transforming Growth Factor-β: Biological Function and Chemical Structure

Sporn, M. B., Roberts, A. B., Wakefield, L. M., & Assoian, R. K. (1986) · Science · doi:10.1126/science.3487831 · Cited by 1,173 · see citing works

Transforming growth factor-beta in disease: the dark side of tissue repair.

Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,096 · see citing works

Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer

Braun, S., Pantel, K., Müller, P. E., Janni, W., Hepp, F., Kentenich, C. R. M., Gastroph, S., Wischnik, A., Dimpfl, T., Kindermann, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420801 · Cited by 923 · see citing works

Deactivation of macrophages by transforming growth factor-β

Tsunawaki, S., Sporn, M. B., Ding, A. H., & Nathan, C. (1988) · Nature · doi:10.1038/334260a0 · Cited by 862 · see citing works

Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

Budd, G. T., Cristofanilli, M., Ellis, M. J., Stopeck, A., Borden, E. C., Miller, M. C., Matera, J., Repollet, M., Doyle, G. V., Terstappen, L. W. M. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1769 · Cited by 776 · see citing works

The TGF-β family of growth and differentiation factors

Massagué, J. (1987) · Cell · doi:10.1016/0092-8674(87)90443-0 · Cited by 672 · see citing works

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

Danila, D. C., Heller, G., Gignac, G. A., Gonzalez-Espinoza, R., Anand, A., Tanaka, E., Lilja, H. G., Schwartz, L. B., Larson, S. M., Fleisher, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1506 · Cited by 665 · see citing works

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.

Rook, A. H., Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Sporn, M. B., Burlington, D. B., Lane, H. C., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3916 · Cited by 570 · see citing works

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562 · see citing works

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Heiser, A., Coleman, D., Dannull, J., Yancey, D. R., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14364 · Cited by 487 · see citing works

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

Bodmer, S., Strommer, K., Frei, K., Siepl, C., de Tribolet, N., Heid, I., & Fontana, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3222 · Cited by 386 · see citing works

Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia

Constam, D. B., Philipp, J., Malipiero, U., ten Dijke, P., Schachner, M., & Fontana, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.5.1404 · Cited by 373 · see citing works

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

Nemunaitis, J. J., Dillman, R. O., Schwarzenberger, P. O., Senzer, N. N., Cunningham, C. C., Cutler, J., Tong, A., Kumar, P., Pappen, B. O., Hamilton, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.5335 · Cited by 365 · see citing works

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., & Sobol, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2909 · Cited by 334 · see citing works

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

Fehm, T. N., Sagalowsky, A. I., Clifford, E., Beitsch, P. D., Saboorian, H. M., Euhus, D., Meng, S., Morrison, L. E., Tucker, T. F., Lane, N., et al. (2002) · PubMed · Cited by 308 · see citing works

Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma

Soiffer, R. J., Hodi, F. S., Haluska, F. G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.005 · Cited by 306 · see citing works

Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non–Small-Cell Lung Carcinoma

Salgia, R., Lynch, T. J., Skarin, A. T., Lucca, J. V., Lynch, C., Jung, K., Hodi, F. S., Jaklitsch, M. T., Mentzer, S. J., Swanson, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.091 · Cited by 296 · see citing works

Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non-Small-Cell Lung Cancer

Nemunaitis, J. J., Sterman, D. H., Jablons, D. M., Smith, J. W., Fox, B. A., Maples, P. B., Hamilton, S., Borellini, F., Lin, A., Moralı, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh028 · Cited by 243 · see citing works

Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma

Takebayashi, Y., Akiyama, S., Yamada, K., Akiba, S., & Aikou, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2 · Cited by 222 · see citing works

Plasma transforming growth factor-?1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma

Kong, F., Jirtle, R. L., Huang, D. H., Clough, R. W., & Anscher, M. S. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991101)86:9 · Cited by 133 · see citing works

Effects of transforming growth factor- beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.

Kasid, A., Bell, G. I., & Director, E. P. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.690 · Cited by 116 · see citing works

Vaccines in cancer: GVAX®, a GM-CSF gene vaccine

Nemunaitis, J. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.3.259 · Cited by 114 · see citing works

Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.

Soria, J., Gauthier, L., Raymond, É., Granotier, C., Morat, L., Armand, J., Boussin, F. D., & Sabatier, L. (1999) · PubMed · Cited by 89 · see citing works

Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor

Hirte, H. W., & Clark, D. A. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01789047 · Cited by 72 · see citing works

A Randomized Study of Immunotherapy with Low-Dose Subcutaneous Interleukin-2 plus Melatonin Vs Chemotherapy with Cisplatin and Etoposide as First-Line Therapy for Advanced Non-Small Cell Lung Cancer

Lissoni, P., Meregalli, S., Fossati, V., et al. (1994) · Tumori Journal · doi:10.1177/030089169408000611 · Cited by 63 · see citing works

Factors, including transforming growth factor β, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells

Ruffini, P. A., Rivoltini, L., Silvani, A., Boiardi, A., & Parmiani, G. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01742258 · Cited by 61 · see citing works

Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.

Jakowlew, S. B., Mathias, A., Chung, P., & Moody, T. W. (1995) · PubMed · Cited by 54 · see citing works

Transforming Growth Factor-β Inhibits Interferon-γ Secretion by Lymph okine-activated Killer Cells Stimulated with Tumor Cells

NAGANUMA, H., SASAKI, A., SATOH, E., NAGASAKA, M., NAKANO, S., ISOE, S., TASAKA, K., & NUKUI, H. (1996) · Neurologia medico-chirurgica · doi:10.2176/nmc.36.789 · Cited by 42 · see citing works

The development of immunotherapies for non-small cell lung cancer

Salgaller, M. L. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.3.265 · Cited by 32 · see citing works

Quantification and Phenotypic Characterization of Circulating Tumor Cells for Monitoring Response to a Preventive HER2/neu Vaccine-Based Immunotherapy for Breast Cancer: A Pilot Study

Stojadinovic, A., Mittendorf, E. A., Holmes, J. P., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9538-x · Cited by 28 · see citing works

Phase II Study of Combined Immunotherapy, Chemotherapy, and Radiotherapy in the Postoperative Treatment of Advanced Non–Small–Cell Lung Cancer

Ratto, G. B., Cafferata, M. A., Scolaro, T., et al. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200001000-00019 · Cited by 17 · see citing works

Correlation of circulating tumor cells with tumor size and metastatic load in a spontaneous lung metastasis model.

Katoh, M., Neumaier, M., Nezam, R., et al. (2004) · PubMed · Cited by 16 · see citing works

Technology evaluation: BLP-25, Biomira Inc.

Morse, M. A. (2001) · PubMed · Cited by 14 · see citing works

Targeting the TGFβ signalling pathway in disease

Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · see citing works

TGFβ biology in cancer progression and immunotherapy

Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944 · see citing works

Targeting TGFβ signal transduction for cancer therapy

Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413 · see citing works

Transforming growth factor‐β in stem cells and tissue homeostasis

Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414 · see citing works

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

Giaccone, G., Bazhenova, L. A., Nemunaitis, J., Tan, M., Juhász, E., Ramlau, R., van den Heuvel, M. M., Lal, R., Kloecker, G. H., Eaton, K. D., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.035 · Cited by 279 · see citing works

Transforming growth factor-β: a therapeutic target for cancer

Haque, S., & Morris, J. C. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1327107 · Cited by 276 · see citing works

Therapeutic cancer vaccines: Are we there yet?

Klebanoff, C. A., Acquavella, N., Yu, Z., & Restifo, N. P. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00979.x · Cited by 271 · see citing works

Kras and tumor immunity: friend or foe?

Cullis, J., Das, S., & Bar-Sagi, D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031849 · Cited by 85 · see citing works

Genetic Modification of the Lung Directed Toward Treatment of Human Disease

Sondhi, D., Stiles, K. M., De, B. P., & Crystal, R. G. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.152 · Cited by 36 · see citing works

Micro-/nanotechnology-based isolation and clinical significance of circulating tumor cells

Kim, E., Kim, S., Choi, K. Y., & Han, K.-H. (2012) · Biomedical Engineering Letters · doi:10.1007/s13534-012-0058-7 · Cited by 7 · see citing works

Isolation of circulating tumor cells under hydrodynamic loading using microfluidic technology(基于微流控技术在流体动力载荷下分离循环肿瘤细胞)

Zhao, C., 李贻昆, 徐睿, 梁纯, 刘大渔, 马薇, Piyawattanametha, W., & Zohar, Y. (2014) · Lixue jinzhan

Circulating Tumor Cell Enrichment Based on Physical Properties

Harouaka, R. A., Nisic, M., & Zheng, S.-Y. (2013) · SLAS TECHNOLOGY · doi:10.1177/2211068213494391 · Cited by 177 · see citing works

State-of-the-arts techniques and current evolving approaches in the separation and detection of circulating tumor cell

He, S., Wei, J., Ding, L., Yang, X., & Wu, Y. (2021) · Talanta · doi:10.1016/j.talanta.2021.123024 · Cited by 35 · see citing works

Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells

Shi, J., Zhao, C.-Q., Shen, M., Chen, Z., Liu, J., Zhang, S., & Zhang, Z. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114025 · Cited by 33 · see citing works